Mutations in gene regulatory regions are thought to play an important role in the evolution of morphological structures. This is largely due to their minimal pleiotropic effects, limiting their impact to one particular body part. A recent study finds that one such regulatory mutation may affect two particular morphological structures.
A major theme in the study of developmental evolution is that regions of DNA which regulate gene expression, such as transcriptional enhancers [1] , are often modified to generate differences in the shape, size, color, or presence of anatomical parts during development [2, 3] . Two principal lines of reasoning explain why enhancers are often implicated in morphological evolution. First, the patterning of gene expression is a particularly important process during development. The unique characteristics of different body parts result, at least in part, from spatially defined patches of gene expression during each structure's formation. It then follows that changing the level, area, or timing of these expression patterns would have substantial effects on phenotype. Second, changes to regulatory regions are thought to have effects that are restricted to one part of the body, minimizing what is known as 'pleiotropy' [4] (Figure 1 ). Genes are often used in different tissues to shape distinct morphologies. Thus, large-effect changes to a protein-coding region would likely be highly pleiotropic, affecting most, if not all tissues where it is expressed. Instead, transcriptional enhancers are separated into modular elements that each generate a portion of the total expression pattern of their target gene. Hence, alterations to an enhancer can circumvent pleiotropic effects by modifying gene expression in only one or a few tissue types [3] . However, if mutations in enhancers are in fact pleiotropic, this would indicate that traits may be linked in unexpected ways, providing a mechanism for the correlated evolution of seemingly unrelated traits. A recent study in Current Biology by Nagy et al. suggests that a single mutation in a pleiotropic enhancer can affect the evolution of two reproductive structures in the fruit fly [5] .
Nagy and colleagues conducted an extensive and elegant genetic analysis of male genital evolution in Drosophila santomea (Figure 1 ). D. santomea has lost two bristles that appear on the hypandrium, a shield-like cuticular plate that surrounds the male phallic organ (Figure 1 ). D. santomea is only 0.5 million years diverged from D. yakuba [6] , which bears hypandrial bristles ( Figure 1 ). The short evolutionary distance separating this species pair permitted the authors to employ quantitative trait mapping crosses to localize a strong effect of the X chromosome on hypandrial bristle number. The authors were then able to cross D. santomea to the more distantly related species D. melanogaster, allowing them to leverage an impressive collection of mutant alleles, deficiencies, and duplications to further narrow down the locus responsible for hypandrial bristle loss to the scute gene. scute encodes a transcription factor with wellcharacterized roles in promoting bristle development [7] .
Armed with an excellent candidate locus, Nagy et al. sought to determine which genetic changes to scute caused D. santomea to lose its hypandrial bristles. Examination of the scute gene revealed identical amino acid sequences between T
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Plei·o·tro·py scute scute scute Current Biology • genetic : two or more apparently unrelated effects due to muation in a single gene.
• enhancer : regulation of expression in multiple tissues by a single enhancer through shared binding sites
• mutational: multiple effects of a single mutation Figure 1 . A single mutation affects two traits.
A single T to G substitution in a pleiotropic enhancer of the gene scute was shown to affect the number of hypandrial bristles in the genitalia and sex comb bristles in legs [5] . Definitions of pleiotropy used throughout the article are listed.
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Dispatches D. santomea and D. yakuba. This is not surprising because scute is involved in establishing bristles across the adult body, most of which are present in D. santomea. In addition, scute has a complex regulatory region, packed with dozens of enhancers that govern distinct patches which express scute across the body to activate bristle development [7] . Alterations to the enhancer responsible for scute's expression in the hypandrium would be the most direct way to modify scute in just two bristles. Using an in vivo test of enhancer function, the authors found that a hypandrial enhancer of scute was disrupted in D. santomea. They identified three individual substitutions which had quantitatively robust effects on the enhancer's function. Surprisingly, the hypandrial enhancer also directed expression to the forelegs. In male flies, the forelegs bear a set of enlarged bristles known as sex combs, which influence male mating success [8] . The number of bristles in the sex comb differs between D. santomea and D. yakuba (Figure 1) , and a portion of this trait maps to the X chromosome [9] . This led the authors to assess whether changes in the hypandrial enhancer of scute drove correlated evolution of these two structures. While the D. santomea enhancer showed reduced function in the genitalia, its activity in the leg was increased relative to D. yakuba (Figure 1 ). Employing an in vivo transgenic assay, Nagy et al. uncovered a single D. santomea mutation which was sufficient to reduce genital bristle number while increasing sex comb bristle number.
Several recent studies have shown that enhancers may play more than one role during development [10] [11] [12] . Nagy et al. takes this one step further by showing how a single regulatory mutation was sufficient to alter two distinct tissues in vivo. This newfound appreciation for the pleiotropy of enhancer regions inspires us to consider mechanisms that could produce this phenomenon ( Figure 2 ). Although enhancer regions are often defined by the smallest section of the genome that can induce expression in a tissue, it has been shown that flanking sequences outside of these minimally defined regions may contribute significantly to their activities [13] . The broader extent or 'sprawl' of these elements may signify that enhancers depicted as separate in the literature actually share binding sites (Figure 2A) . Similarly, enhancers that were initially separate elements may later fuse together if intervening sequences are deleted, a process that is quite common in Drosophila genomes [14] ( Figure 2B) . It is also possible that mechanisms generating new expression patterns may result in pleiotropy. In particular, when a preexisting enhancer is co-opted to become active in an additional tissue [15] , binding sites will be shared between the ancestral and derived enhancer activities, increasing their pleiotropy ( Figure 2C ). During the cooption of entire gene regulatory networks, genes participating in one network are deployed to a new tissue through the activation of upstream transcription factors [16] . The result of such a dramatic network-wide change is that large numbers of enhancers in the co-opted network will experience increased pleiotropy [10] (Figure 2D) .
Considering the many routes through which pleiotropy may emerge in enhancer regions, it seems quite likely that this phenomenon is more widespread than previously thought. This may in part be due to the manner in which most enhancers are characterized. Typically, researchers focus on only one tissue, and are unlikely to test other tissues or developmental stages for pleiotropic activities. This might be remedied by large unbiased screens of enhancers in multiple tissues which can help identify an enhancer's pleiotropic activities [17, 18] . Ultimately, to confirm the pleiotropy of an enhancer, evidence that the same binding site is necessary to drive expression in two unrelated tissues is required [10, 11] . Far more difficult is identifying the pleiotropic consequences of evolutionarily relevant mutations. A single gene or enhancer may have multiple mutations that each affect different phenotypes, generating the illusion of mutational pleiotropy. It is only through the dissection of causative genes to their underlying mutations that we can directly observe this elusive phenomenon. The study by Nagy et al. highlights how such meticulous analyses can illuminate insights that go beyond simply finding genes and mutations that generate phenotypes. Although pleiotropic enhancers are part of an emerging reality, it is important to note that they control the expression of only a subset of the tissues where the regulated gene is used, and are thus less pleiotropic than the coding regions they regulate. Pleiotropic enhancers instead provide us with a genetic mechanism to explain how some tissues are more connected than others, and why we find correlated evolution between seemingly unrelated traits. As we obtain a better sense for how commonly pleiotropy exists among enhancers, the next challenge will be to determine how well this predicts the pleiotropy of mutations to these elements. It may become apparent that there are many mutations that modify the activity of a pleiotropic enhancer in one tissue without affecting the other tissue [12] . Understanding these broader trends will be significant, as we begin to tackle the problem of which (if any) of the affected traits was subject to selection. For now, the open question remains: how many phenotypes do regulatory mutations affect?
The crystal structure of SelO, a pseudokinase previously presumed to be inactive, reveals an ATP cofactor sitting in the active site in a flipped orientation compared with canonical kinases, leading to the discovery of an unexpected catalytic activity for this ancient enzyme.
Protein kinases -enzymes that attach phosphate groups to target proteins -are critical players in cell regulation and disease pathology, and are prized for being highly druggable targets. The kinase family is among the largest of protein families; however, about one in every ten protein kinases, identified as such on the basis of sequence homology, lacks one or more of the residues required for catalytic activity. These so-called pseudokinases have been a source of mystery and speculation since they were first discovered. A recent study by Sreelatha et al. [1] now reveals that the highly conserved pseudokinase SelO possesses an unexpected and 'inverted' catalytic activity for a protein kinase domain.
The widespread presence of pseudokinase genes in the human genome was first discovered over 15 years ago [2, 3] . Many hypotheses arose over the years to explain these kinases. Perhaps they a have weak catalytic activity supported by compensatory mutations. Perhaps they allosterically regulate other proteins to which they bind, or act as scaffolds by binding to enzyme-substrate pairs and bringing them into close proximity with
